Today we remember and support #WorldAIDSDay. Medical research has seen amazing advances and milestones over the past few decades. Here at IRBM, we are proud to have played a major role in the discovery of Raltegravir (Isentress) while part of Merck & Co, for the treatment of #HIV-1 infection in combination with other antiretroviral agents.
World Vaccine Congress Washington 2019
Stefania Di Marco, Ph.D., Qualified Person of ADVENT, and Daniel Conlon, IRBM’s VP of Business Development, North America, will be attending the World Vaccine Congress in Washington, D.C. from April 14 to April 17. To learn more about ADVENT’s capabilities, and how this cGMP CMO facility can support your vaccine development and manufacturing, feel free to contact us to organize a meeting.
Related Posts
